Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
This guide weighs the advantages and drawbacks of target date versus lifecycle funds to help you pick the option that best fits your retirement plan.
25,428 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
As Veracyte approaches its Q4 2025 earnings, investors want a clear view of revenue momentum, margins, and reimbursem...
Ethereum surged to a six-week high as institutional buying and treasury activity boosted ETH. This article breaks dow...
A geopolitical chokepoint isn't just about oil. The Strait of Hormuz also moves a vital portion of global fertilizer....
A noted economist who studied sports money foresees a record run for FIFA, with 2026 ticket receipts pushing revenue ...
Mortgage rates remain above 6.7% amid persistent inflation concerns and a solid jobs market, with housing demand show...
Amid a regulatory push, centralized venues pull privacy assets from listings, yet GhostSwap keeps Monero and other co...
June inflation data surprised to the downside, lifting Bitcoin and other risk assets. Yet traders remain wary of a Se...
Bitcoin breaks back above $68,000 to lead a crypto rebound, with Circle’s revenue surge and NEAR’s jump signaling sus...
Chase has cut credit-card limits for some customers with minimal usage, raising questions about credit-score impact a...
Investors are weighing how legal rulings against Meta could reshape risk and earnings. This guide breaks down what ha...
Bitcoin sits at a pivotal crossroads as on-chain and technical indicators converge around the $70K realized price ban...